These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1553002)

  • 1. Significance of high levels of heparin cofactor II in the plasma and urine of adult patients with nephrotic syndrome.
    Toulon P; Gandrille S; Remy P; Chadeuf G; Jouvin MH; Aiach M
    Nephron; 1992; 60(2):176-80. PubMed ID: 1553002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis.
    Toulon P; Vitoux JF; Fiessinger JN; Sicard D; Aiach M
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):435-9. PubMed ID: 1718466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P; Bardin JM; Blumenfeld N
    Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wall.
    Pasche B; Swedenborg J; Frebelius S; Olsson P
    Thromb Res; 1991 Jun; 62(5):409-19. PubMed ID: 1896960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
    Mackie IJ; Segal H; Burren T; Gallimore M; Walshe KJ; Robinson G; Machin SJ
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):647-51. PubMed ID: 2133244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor II.
    Porter JB; Young L; Mackie IJ; Marshall L; Machin SJ
    Br J Haematol; 1993 Mar; 83(3):459-65. PubMed ID: 8485052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heparin cofactor II (HCII) activity and antigen assay and their significance in thrombotic diseases].
    Dai CW; Zhang GS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):452-4. PubMed ID: 14575585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low plasma heparin cofactor II levels in thalassaemia syndromes are corrected by chronic blood transfusion.
    O'Driscoll A; Mackie IJ; Porter JB; Machin SJ
    Br J Haematol; 1995 May; 90(1):65-70. PubMed ID: 7786797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of heparin cofactor II in the modulation of hemostasis.
    Salem HH; Thompson EA
    Dev Biol Stand; 1987; 67():67-72. PubMed ID: 3301469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation.
    Noda A; Wada H; Kusiya F; Sakakura M; Onishi K; Nakatani K; Gabazza EC; Asahara N; Tsukada M; Nobori T; Shiku H
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):265-71. PubMed ID: 12361205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of heparin and their effect on heparin cofactor II mediated inhibition of thrombin.
    Kim YS; Linhardt RJ
    Thromb Res; 1989 Jan; 53(1):55-71. PubMed ID: 2922702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
    Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome.
    Vaziri ND; Paule P; Toohey J; Hung E; Alikhani S; Darwish R; Pahl MV
    Arch Intern Med; 1984 Sep; 144(9):1802-3. PubMed ID: 6477000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells.
    Kaji T; Itoh F; Hayakawa Y; Oguma Y; Sakuragawa N
    Thromb Res; 1989 Oct; 56(1):99-107. PubMed ID: 2512688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enzyme-linked immunosorbent assay for heparin cofactor II (HCII). Application to the measurement of HCII in clinical materials.
    Toulon P; Costa JM; Amiral J
    Clin Chim Acta; 1992 Jan; 205(1-2):65-73. PubMed ID: 1521342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma heparin cofactor II and antithrombin III concentrations in adult nephrotic syndrome.
    Hannedouche T; Fischer AM; Blanche P; Tapon-Brétaudière J; Ganeval D
    Clin Nephrol; 1987 Dec; 28(6):305-6. PubMed ID: 3442960
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure.
    Tollefsen DM; Pestka CA
    Blood; 1985 Oct; 66(4):769-74. PubMed ID: 4041618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin action of phosvitin and other phosphate-containing polyanions is mediated by heparin cofactor II.
    Church FC; Pratt CW; Treanor RE; Whinna HC
    FEBS Lett; 1988 Sep; 237(1-2):26-30. PubMed ID: 3169238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of heparin cofactor II in injured human skin: a potential role in wound healing.
    Hoffman M; Loh KL; Bond VK; Palmieri D; Ryan JL; Church FC
    Exp Mol Pathol; 2003 Oct; 75(2):109-18. PubMed ID: 14516771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.